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Synthesis of multisubstituted pyrroles by nickel-catalyzed 
arylative cyclizations of N-tosyl alkynamides†  
Simone M. Gillbard,‡ab Chieh-Hsu Chung,‡ab Somnath Narayan Karad,ab Heena Panchal,ab William 
Lewisb and Hon Wai Lam*ab  
The synthesis of multisubstituted pyrroles by the nickel-catalyzed reaction of N-tosyl alkynamides with arylboronic acids is 
reported. These reactions are triggered by alkyne arylnickelation, followed by cyclization of the resulting alkenylnickel 
species onto the amide. The reversible E/Z isomerization of the alkenylnickel species is critical for cyclization. This method 
was applied to the synthesis of pyrroles that are precursors to BODIPY derivatives and a biologically active compound.  
Pyrroles are common heterocycles that appear in natural products,1 
pharmaceuticals,2 dyes,3 and organic materials.4 Representative 
pyrrole-containing natural products include lamellarin D5,6 and 
lycogarubin C,7 whereas drugs that contain a pyrrole include 
sunitinib8 and atorvastatin9 (Figure 1). In view of their importance, 
numerous strategies to prepare pyrroles have been developed.10,11  
 
 
Figure 1  Representative pyrrole-containing natural products and drugs 
 
We12 and others13 have recently described nickel-catalyzed anti-
carbometallative cyclizations of alkynyl electrophiles that give 
various carbo- and heterocyclic products. Although these reactions 
utilized several types of electrophiles,12,13 amides have yet to be 
described, which is perhaps unsurprising given their relatively low 
electrophilicity. Nevertheless, the successful use of amides could 
provide a versatile synthesis of multisubstituted pyrroles, as shown 
in Scheme 1. Nickel-catalyzed addition of an arylboronic acid to the 
 
Scheme 1 Proposed synthesis of pyrroles 
 
alkynamide 1 would give alkenylnickel species (E)-2. Although (E)-
2 cannot cyclize onto the amide because of geometric constraints, 
reversible E/Z isomerization of (E)-2 would provide (Z)-2, which 
could now attack the amide to give nickel alkoxide 4. Incorporating 
an electron-withdrawing N-tosyl group into 1 was expected to 
increase the reactivity of the amide carbonyl to favor this 
nucleophilic addition. Protonation of 4, followed by elimination of 
water, would then provide a 2,3,4-trisubstituted pyrrole 3. 
Our investigations began with the reaction of alkynamide 1a with 
PhB(OH)2 to give pyrrole 3aa, which was conducted in the presence 
of Ni(OAc)2·4H2O (10 mol%) in 2,2,2-trifluoroethanol (TFE) at 80 
°C for 24 h (Table 1, entry 1). However, 3aa was not detected in this 
reaction. Next, various P,N-ligands (10 mol%) were added (entries 
2–7). The achiral ligand L1 gave 3aa in 27% yield as determined by 
1H NMR analysis, but significant quantities of 1a remained (entry 2). 
Chiral phosphinooxazolines L2–L6 were then examined (entries 3–
7) and of these, (R)-Ph-PHOX (L2) gave 3aa in 90% NMR yield 
with no starting material remaining (entry 3).  
With an effective ligand identified, the scope of the alkynamide 
was surveyed in reactions with PhB(OH)2 (Table 2). Here, racemic 
L2 was used and satisfactory results were obtained using a reduced 
catalyst loading of 5 mol%.These experiments gave pyrroles 3aa–
3ma in 46–99% yield.14 Regarding the alkyne substituent, the 
reaction is compatible with a phenyl group (3aa), various para- (3ba  
Communication ChemComm 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
Table 1  Evaluation of reaction conditionsa 
 
Entry Ligand Yield of 1a [%]b Yield of 3aa [%]b 
1 – >95 <5 
2 L1 33 27 
3 L2 – 90 
4 L3 18 52 
5 L4 13 70 
6 L5 10 63 
7 L6 11 52 
a Reactions were conducted with 0.05 mmol of 1a. b Determined by 1H NMR 
analysis using 1,4-dimethoxybenzene as an internal standard.  
 
and 3ca), meta- (3da), and ortho-substituted phenyl groups (3ea), 
and a 2-thienyl group (3fa). Replacement of the benzoyl group of the 
amide with various para-substituted benzenes is also possible (3ga 
and 3ha15). N-Acyl groups with alkyl substituents are also tolerated. 
For example, pyrroles containing methyl (3ia), n-butyl (3ja), 
cyclopropyl (3ka), or cyclohexyl (3la) groups were formed in 54– 
 
Table 2  Scope of alkynamidesa 
 
a Reactions were conducted with 0.30 mmol of 1a–1m in TFE (3 mL). Yields 
are of isolated products. b An acyclic tetrasubstituted alkene was also isolated 
in 23% yield (see Supplementary Information). c Conducted at 120 °C. 
92% yield, although for 3la, increasing the temperature to 120 °C 
was required for high conversion. The process is not limited to 
aromatic groups at the alkyne, as shown by the reaction of 1,3-enyne 
1m to give pyrrole 3ma in 99% yield. However, a substrate 
containing a methyl group on the alkyne only gave a complex 
mixture of products. Furthermore, the N-tosyl group is important for 
reactivity, as N-aryl alkynamides failed to cyclize. 
 
 
 
 The cyclization of carbomethoxy-containing substrate 1n failed 
under the standard conditions, and led only to decomposition by 
cleavage of the methyl oxalyl group. However, changing the solvent 
to THF and increasing the catalyst loading to 20 mol% successfully 
gave pyrrole 3na in 35% yield, along with 3-pyrroline 5na in 38% 
yield (eqn 1). Increasing the temperature to 120 °C improved the 
yield of 3na to 73%, and none of 5na was observed (eqn 2). 
 
Table 3 Scope of boronic acidsa 
 
a Reactions were conducted with 0.30 mmol of 1a in TFE (3 mL). Yields are 
of isolated products. 
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 Pleasingly, this process is compatible with 
various(hetero)arylboronic acids, and pyrroles 3ab–3aj were 
obtained in 63–90% yield from alkynyamide 1a  (Table 3). The 
scope includes para- (3ab), meta- (3ac and 3ad), ortho- (3ae), and 
disubstituted phenylboronic acids (3af–3ah) with methyl (3ab and 
3ah), halide (3ad, 3ae, and 3ag), or alkoxy groups (3ac, 3af, and 
3ag). 2-Naphthylboronic acid (3ai) and various heteroarylboronic 
acids that include 5-indolylboronic acid (3aj), 3-furanylboronic acid 
(3ak), and 3-thienylboronic acid (3al) are also tolerated. No reaction 
was observed when 4-pyridinylboronic acid, methylboronic acid, or 
cyclopropylboronic acid were used. 
 To illustrate its utility, this methodology was applied to the 
preparation of pyrroles that have been used in the synthesis of 4,4-
difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) derivatives 
(Scheme 2).3a,b,d Removal of the tosyl group from 3aa with KOH in 
MeOH/TFH (1:1) at 70 °C gave pyrrole 6 in >99% yield, which has 
previously been converted into BODIPY derivative 7.16 
Alternatively, treatment of 3aa with POCl3 in DMF at 100 °C in a 
microwave reactor resulted in formylation with concomitant removal 
of the tosyl group to give pyrrole 8, which has been used in the 
synthesis of BODIPY derivative 9.16 
 
 
Scheme 2 Synthesis of precursors to BODIPY derivatives 
 
In a further application, removal of the tosyl group of 3ia with  
KOH was followed by immediate alkylation with  n-hexyl bromide 
as described previously to give pyrrole 10 in 56% yield over two 
steps (Scheme 3).17 Pyrrole 10 was previously converted in two steps 
into 11, a known inhibitor of bovine cyclooxygenase and 5-
lipoxygenase.17 
 
 
Scheme 3 Formal synthesis of bovine cyclooxygenase and 5-lipoxygenase 
inhibitor 11 
 
In conclusion, we have developed a synthesis of diverse 2,3,4-
trisubstituted pyrroles by the nickel-catalyzed reaction of N-tosyl 
alkynamides with arylboronic acids. These reactions rely upon the 
reversible E/Z isomerization of alkenylnickel species as a key step to 
enable cyclization to take place. This method was applied to the 
synthesis of pyrroles that are precursors to BODIPY derivatives, as 
well as an inhibitor of bovine cyclooxygenase and 5-lipoxygenase. 
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